Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

Christine Simmons; Daniel Rayson; Anil Abraham Joy; Jan Willem Henning; Julie Lemieux; Heather McArthur; Paul B. Card; Rebecca Dent; Christine Brezden-Masley

doi:10.1177/17588359211066677

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

Christine Simmons, Daniel Rayson, Anil Abraham Joy, Jan Willem Henning, Julie Lemieux, Heather McArthur, Paul B. Card, Rebecca Dent, Christine Brezden-Masley

Computer Science

Research output: Contribution to journal › Review article › peer-review

24 Citations (Scopus)

Original language	English
Journal	Therapeutic Advances in Medical Oncology
Volume	14
DOIs	https://doi.org/10.1177/17588359211066677
Publication status	Published - Jan 2022

ASJC Scopus Subject Areas

Oncology

Keywords

HER2-positive
T-DM1
T-DXd
advanced disease
breast cancer
neratinib
pertuzumab
trastuzumab
tucatinib

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/17588359211066677

Cite this

Simmons, C., Rayson, D., Joy, A. A., Henning, J. W., Lemieux, J., McArthur, H., Card, P. B., Dent, R., & Brezden-Masley, C. (2022). Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines. Therapeutic Advances in Medical Oncology, 14. https://doi.org/10.1177/17588359211066677

@article{6ce2f3641f1f4d14a7c0114c82c4ed8b,

title = "Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines",

keywords = "HER2-positive, T-DM1, T-DXd, advanced disease, breast cancer, neratinib, pertuzumab, trastuzumab, tucatinib",

author = "Christine Simmons and Daniel Rayson and Joy, {Anil Abraham} and Henning, {Jan Willem} and Julie Lemieux and Heather McArthur and Card, {Paul B.} and Rebecca Dent and Christine Brezden-Masley",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2022.",

year = "2022",

month = jan,

doi = "10.1177/17588359211066677",

language = "English",

volume = "14",

journal = "Therapeutic Advances in Medical Oncology",

issn = "1758-8340",

publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Current and future landscape of targeted therapy in HER2-positive advanced breast cancer

T2 - redrawing the lines

AU - Simmons, Christine

AU - Rayson, Daniel

AU - Joy, Anil Abraham

AU - Henning, Jan Willem

AU - Lemieux, Julie

AU - McArthur, Heather

AU - Card, Paul B.

AU - Dent, Rebecca

AU - Brezden-Masley, Christine

N1 - Publisher Copyright: © The Author(s), 2022.

PY - 2022/1

Y1 - 2022/1

KW - HER2-positive

KW - T-DM1

KW - T-DXd

KW - advanced disease

KW - breast cancer

KW - neratinib

KW - pertuzumab

KW - trastuzumab

KW - tucatinib

UR - http://www.scopus.com/inward/record.url?scp=85122959114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122959114&partnerID=8YFLogxK

U2 - 10.1177/17588359211066677

DO - 10.1177/17588359211066677

M3 - Review article

AN - SCOPUS:85122959114

SN - 1758-8340

VL - 14

JO - Therapeutic Advances in Medical Oncology

JF - Therapeutic Advances in Medical Oncology

ER -

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this